The CRISPR-Cas9 system can be programmed to target specific stretches of genetic code and to make cuts at precise locations.

To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video

Genome Editing with CRISPR – Cas9

Anne Trafton | November 5, 2014May 24, 2023

Categories: Genome Engineering, Addiction, ADHD, ALS, Alzheimer’s Disease, Anxiety, Autism Spectrum Disorder, Bipolar Disorder, Depression, Huntington’s Disease, Obsessive-Compulsive Disorder, Parkinson’s Disease, Schizophrenia, Feng Zhang

The CRISPR-Cas9 system can be programmed to target specific stretches of genetic code and to make cuts at precise locations.

This animation depicts the CRISPR-Cas9 method for genome editing – a powerful new technology with many applications in biomedical research, including the potential to treat human genetic disease. Feng Zhang, a leader in the development of this technology, is a faculty member at MIT, an investigator at the McGovern Institute for Brain Research, and a core member of the Broad Institute.

Faculty

Principal Research Scientists

Focus Areas

Disorder Areas

Genome Editing with CRISPR – Cas9

Symposium highlights scale of mental health crisis and novel methods of diagnosis and treatment

Beyond the brain

Simons Center’s collaborative approach propels autism research, at MIT and beyond